← Back to Clinical Trials
Recruiting NCT06638060

NCT06638060 Continuous Connected Patient Care (CCPC), a Pilot Testing a Novel Device for Continuous Vitals Monitoring - Older Adults Department PHC

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06638060
Status Recruiting
Phase
Sponsor Medtronic - MITG
Condition Aging
Study Type OBSERVATIONAL
Enrollment 15 participants
Start Date 2025-03-13
Primary Completion 2026-06-21

Eligibility & Interventions

Sex All sexes
Min Age 65 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 15 participants in total. It began in 2025-03-13 with a primary completion date of 2026-06-21.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

To confirm feasibility and accessibility of the CCPC Platform (Oxymotion, Bridge Health Solutions medication adherence software, CloudDX home kit) in two different environments - 1) hospital (Acute Care for Elderly Unit) and 2) at-home .

Eligibility Criteria

Inclusion Criteria: * Inpatients on the Acute care of the Elderly ward. Exclusion Criteria: * Lack of capacity to consent to the study including moderate-severe dementia or delirium * Unable to use (or does not have a caregiver who can help put on) study monitoring device at home * Unable to complete (or does not have a caregiver who can help complete) study questionnaires by electronic (mobile, tablet, or computer), paper, nor phone * Patient with known allergic reactions to any part material of the device * People under 40kg

Contact & Investigator

Central Contact

Elise Huisman

✉ elise.huisman@medtronic.com

📞 +1 236-308-4876

Frequently Asked Questions

Who can join the NCT06638060 clinical trial?

This trial is open to participants of all sexes, aged 65 Years or older, studying Aging. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06638060 currently recruiting?

Yes, NCT06638060 is actively recruiting participants. Contact the research team at elise.huisman@medtronic.com for enrollment information.

Where is the NCT06638060 trial being conducted?

This trial is being conducted at Vancouver, Canada.

Who is sponsoring the NCT06638060 clinical trial?

NCT06638060 is sponsored by Medtronic - MITG. The trial plans to enroll 15 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology